Laure S. Fournier

Suggest Changes
Learn More
BACKGROUND AND OBJECTIVES Objective response as determined by Response Evaluation Criteria in Solid Tumors (RECIST) is low among patients with metastatic renal cell carcinoma (mRCC) treated with(More)